Data from the All India Organisation of Chemists & Druggists (AIOCD) showed that in the June 2020-May 2021 period, Indians bought Rs 1,220 ...

Bajaj Healthcare said it has successfully developed the active pharmaceutical ingredient and the formulation for Ivermectin through its own...

The task force headed by Niti Aayog member Vinod Paul decided against recommending ivermectin due to lack of evidence even as doctors, incl...

The experts will also review evidence on anti-parasitic drug ivermectin. “The task force will review the overall Covid situation. Along wit...

Ivermectin is now in a position where hydroxychloroquine (HCQ) was earlier. Doctors have started prescribing it widely even though there is...

Over 50 clinical trials for a Covid-19 vaccine have started in India as researchers globally look for ways to stop the ravaging pandemic.

CEO of Novalead, told ET that the firm will start phase 3 randomised trials to study whether the generic drug nitazoxanide brings down the ...

Bengaluru, April 27 (IANS) In a stunningly successful trial, scientists report they cured 18 critically-ill patients suffering from drug-re...

The discovery could potentially make malaria treatment significantly more effective for the 3.2 billion people at risk.

Robot scientists can automatically develop and test hypotheses to explain observations, run experiments using laboratory robotics.

'Artemisinin-naphthoquine drug-combo should be considered for the treatment of uncomplicated malaria in settings where multiple parasite sp...

Australian researchers said that a new drug that stops the malaria parasite from using vitamin B1 to multiply is now plausible.

Scientists claim to have discovered a drug that could cure all strains of malaria with a single oral dose and also block transmission of th...

India has developed a powerful new malaria drug - an alternative to the global drug of choice Artemisinin - that promises to be a major boo...

A new research has warned that drug-resistant malaria parasites on the border of Thailand & Myanmar may spread to India.

Ranbaxy Laboratories, India's largest drugmaker by sales, on Monday announced that its new anti-malarial combination drug is now undergoing...

: In a major breakthrough, biochemists of the Indian Institute of Science, Bangalore have found that the anti-cancer drug and the inhibitor...